Notice2021-15792

Agency Forms Undergoing Paperwork Reduction Act Review

Primary source

Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.

Published
July 26, 2021

Issuing agencies

Health and Human Services DepartmentCenters for Disease Control and Prevention

Full Text

<html>
<head>
<title>Federal Register, Volume 86 Issue 140 (Monday, July 26, 2021)</title>
</head>
<body><pre>
[Federal Register Volume 86, Number 140 (Monday, July 26, 2021)]
[Notices]
[Pages 40048-40050]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2021-15792]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[30Day-21-1169]


Agency Forms Undergoing Paperwork Reduction Act Review

    In accordance with the Paperwork Reduction Act of 1995, the Centers 
for Disease Control and Prevention (CDC) has submitted the information 
collection request titled ``Development of CDC's Let's Stop HIV 
Together Social Marketing Campaign for Consumers'' to the Office of 
Management and budget (OMB) for review and approval. CDC previously 
published a ``Proposed Data Collection Submitted for Public Comment and 
Recommendations'' notice on March 12, 2021 to obtain comments from the 
public and affected agencies. CDC did not receive comments related to 
the previous notice. This notice serves to allow an additional 30 days 
for public and affected agency comments.
    CDC will accept all comments for this proposed information 
collection project. The Office of Management and Budget is particularly 
interested in comments that:
    (a) Evaluate whether the proposed collection of information is 
necessary for the proper performance of the functions of the agency, 
including whether the information will have practical utility;
    (b) Evaluate the accuracy of the agencies estimate of the burden of 
the proposed collection of information, including the validity of the 
methodology and assumptions used;
    (c) Enhance the quality, utility, and clarity of the information to 
be collected;
    (d) Minimize the burden of the collection of information on those 
who

[[Page 40049]]

are to respond, including, through the use of appropriate automated, 
electronic, mechanical, or other technological collection techniques or 
other forms of information technology, e.g., permitting electronic 
submission of responses; and
    (e) Assess information collection costs.
    To request additional information on the proposed project or to 
obtain a copy of the information collection plan and instruments, call 
(404) 639-7570. Comments and recommendations for the proposed 
information collection should be sent within 30 days of publication of 
this notice to <a href="http://www.reginfo.gov/public/do/PRAMain">www.reginfo.gov/public/do/PRAMain</a>. Find this particular 
information collection by selecting ``Currently under 30-day Review--
Open for Public Comments'' or by using the search function. Direct 
written comments and/or suggestions regarding the items contained in 
this notice to the Attention: CDC Desk Officer, Office of Management 
and Budget, 725 17th Street NW, Washington, DC 20503 or by fax to (202) 
395-5806. Provide written comments within 30 days of notice 
publication.

Proposed Project

    Development of CDC's Let's Stop HIV Together Social Marketing 
Campaign for Consumers--Reinstatement--National Center for HIV/AIDS, 
Viral Hepatitis, STD and TB Prevention (NCHHSTP), Centers for Disease 
Control and Prevention (CDC).

Background and Brief Description

    To address the HIV epidemic in the U.S., the Department of Health 
and Human Services launched Ending the HIV Epidemic: A Plan for 
America, which is a cross-agency initiative aiming to reduce new HIV 
infections in the U.S. by 90% by 2030. CDC's Let's Stop HIV Together 
campaign (formerly known as Act Against AIDS) is part of the national 
Ending the HIV Epidemic initiative and includes resources aimed at 
reducing HIV stigma and promoting testing, prevention, and treatment 
across the HIV care continuum.
    Within this context, CDC's Division of HIV/AIDS Prevention (DHAP) 
has and will continue implementing various communication initiatives to 
increase HIV awareness among the general public, reduce new HIV 
infections among disproportionately impacted populations, and improve 
health outcomes for people living with HIV/AIDS in the US and its 
territories. Specifically, the campaigns target consumers aged 18 to 64 
years old and includes the following audiences: (1) General public; (2) 
Men who have sex with men; (3) Blacks/African Americans; (4) Hispanics/
Latinos; (5) Transgender individuals; (6) people who inject drugs; and 
(7) people with HIV (PWH).
    The rounds of data collection include exploratory, message testing, 
concept testing, and materials testing. Information collected by DHAP 
will be used to assess consumers' informational needs about HIV 
testing, prevention, and treatment and pre-test campaign related 
messages, concepts, and materials and evaluate the extent to which the 
communication initiatives are reaching the target audiences and 
providing them with trusted HIV-related information. Data collections 
will include in-depth interviews, focus groups, brief surveys, and 
intercept interviews.
    The data gathered under this request will be summarized in reports 
prepared for CDC by its contractor, such as quarterly and annual 
reports and topline reports that summarize results from each data 
collection. It is possible that data from this project will be 
published in peer-reviewed manuscripts or presented at conferences; the 
manuscripts and conference presentations may appear on the internet.
    The total estimated annualized burden hours are 1,856. 
Participation by respondents is voluntary, and there is no cost to 
participants other than their time.

                                        Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
                                                                                                      Average
                                                                     Number of       Number of      burden per
         Type of respondent                    Form name            respondents    responses per   response  (in
                                                                                    respondent        hours)
----------------------------------------------------------------------------------------------------------------
Health care providers...............  Study screener............           2,165               1            2/60
                                      Exploratory--HIV Testing                50               1               1
                                       In-depth Interview.
                                      Exploratory--HIV                        52               1               1
                                       Prevention In-depth
                                       Interview.
                                      Exploratory--HIV                        50               1               1
                                       Communication and
                                       Awareness In-depth
                                       Interview.
                                      Exploratory--HIV                        50               1               1
                                       Prevention with Positives
                                       In-depth Interview.
                                      Message Testing In-depth                50               1               1
                                       Interview.
                                      Concept Testing In-depth                50               1               1
                                       Interview.
                                      Materials Testing In-depth              50               1               1
                                       Interview.
                                      Exploratory--HIV Testing                74               1               2
                                       Focus Group.
                                      Exploratory--HIV                        74               1               2
                                       Prevention Focus Group.
                                      Exploratory--HIV                        74               1               2
                                       Communication and
                                       Awareness Focus Group.
                                      Exploratory--HIV                        74               1               2
                                       Prevention with Positives
                                       Focus Group.
                                      Concept Testing Focus                   68               1               2
                                       Group.
                                      Message Testing Focus                   68               1               2
                                       Group.
                                      Materials Testing Focus                 68               1               2
                                       Group.
                                      HIV Testing Survey........             213               1           15/60
                                      HIV Prevention Survey.....             213               1           15/60
                                      HIV Communication and                  213               1           15/60
                                       Awareness Survey.
                                      HIV Prevention with                    213               1           15/60
                                       Positives Survey.
                                      Intercept Interview.......             657               1           20/60
----------------------------------------------------------------------------------------------------------------



[[Page 40050]]

Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Scientific 
Integrity, Office of Science, Centers for Disease Control and 
Prevention.
[FR Doc. 2021-15792 Filed 7-23-21; 8:45 am]
BILLING CODE 4163-18-P


</pre></body>
</html>
Indexed from Federal Register on July 26, 2021.

This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.